Dr. Marshall Ching, M.D

NPI: 1215036835
Total Payments
$18.3M
2024 Payments
$611,360
Companies
15
Transactions
52
Medicare Patients
2,542
Medicare Billing
$490,794

Payment Breakdown by Category

Royalty/License$16.5M (90.3%)
Other$1.8M (9.7%)
Food & Beverage$920.19 (0.0%)
Travel$695.83 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $16.5M 12 90.3%
Acquisitions $1.8M 6 9.7%
Food and Beverage $920.19 26 0.0%
Travel and Lodging $695.83 6 0.0%
Unspecified $0 2 0.0%

Payments by Type

General
$18.3M
50 transactions
Ownership
$0
2 transactions

Top Paying Companies

Company Total Records Latest Year
Medtronic MiniMed, Inc. $14.7M 4 $0 (2020)
Medtronic, Inc. $1.8M 6 $0 (2024)
Medtronic Vascular, Inc. $1.4M 7 $0 (2019)
Medtronic USA, Inc. $447,206 1 $0 (2019)
Zimmer Biomet Holdings, Inc. $1,181 9 $0 (2024)
Flexion Therapeutics, Inc. $164.48 11 $0 (2020)
Sonex Health, Inc. $56.57 2 $0 (2021)
Pacira Pharmaceuticals Incorporated $54.05 2 $0 (2024)
Pacira Therapeutics, Inc. $48.76 3 $0 (2021)
Ethicon US, LLC $33.52 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $611,360 7 Medtronic, Inc. ($610,829)
2022 $0 1 BlackSwan Vascular, Inc.
2021 $1.2M 9 Medtronic, Inc. ($1.2M)
2020 $14.7M 8 Medtronic MiniMed, Inc. ($14.7M)
2019 $1.3M 13 Medtronic Vascular, Inc. ($879,024)
2018 $487,021 14 Medtronic Vascular, Inc. ($486,850)

All Payment Transactions

52 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/07/2024 Heron Therapeutics, Inc. ZYNRELEF (Drug) Food and Beverage In-kind items and services $22.70 General
Category: POST SURGICAL PAIN RELIEF
09/05/2024 Medtronic, Inc. INPEN SMART INSULIN DELIVERY SYSTEM (Device) Acquisitions Cash or cash equivalent $387,769.22 General
Category: Continuous Glucose Monitoring
09/05/2024 Medtronic, Inc. INPEN SMART INSULIN DELIVERY SYSTEM (Device) Acquisitions Cash or cash equivalent $223,060.12 General
Category: Continuous Glucose Monitoring
07/16/2024 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $21.04 General
Category: Pain Management
06/19/2024 Ethicon US, LLC STRATAFIX (Device) Food and Beverage In-kind items and services $33.52 General
Category: Wound Closure
06/12/2024 Zimmer Biomet Holdings, Inc. ROSA (Device) Food and Beverage In-kind items and services $420.88 General
Category: Knees
05/14/2024 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $33.01 General
Category: Pain Management
2022 BlackSwan Vascular, Inc. $0.00 Ownership
12/20/2021 Medtronic, Inc. InPen (Device) Acquisitions Cash or cash equivalent $401,436.06 General
Category: Continuous Glucose Monitoring
12/20/2021 Medtronic, Inc. InPen (Device) Acquisitions Cash or cash equivalent $230,921.81 General
Category: Continuous Glucose Monitoring
08/26/2021 Pacira Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $12.61 General
Category: Musculoskeletal
07/15/2021 Pacira Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $18.62 General
Category: Musculoskeletal
06/02/2021 Pacira Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $17.53 General
Category: Musculoskeletal
01/29/2021 Medtronic, Inc. Acquisitions Cash or cash equivalent $429,318.00 General
01/29/2021 Medtronic, Inc. Acquisitions Cash or cash equivalent $92,825.51 General
01/14/2021 Sonex Health, Inc. ULTRAGUIDECTR (Device) Food and Beverage In-kind items and services $17.00 General
Category: ORTHOPEDIC
2021 BlackSwan Vascular, Inc. $0.00 Ownership
12/10/2020 Medtronic MiniMed, Inc. InPen (Device) Royalty or License Cash or cash equivalent $1,772,393.80 General
Category: Continuous Glucose Monitoring
12/10/2020 Medtronic MiniMed, Inc. InPen (Device) Royalty or License Cash or cash equivalent $1,019,550.60 General
Category: Continuous Glucose Monitoring
10/21/2020 Flexion Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $16.07 General
Category: Musculoskeletal
09/10/2020 Medtronic MiniMed, Inc. InPen (Device) Royalty or License Cash or cash equivalent $7,563,587.00 General
Category: Continuous Glucose Monitoring
09/10/2020 Medtronic MiniMed, Inc. InPen (Device) Royalty or License Cash or cash equivalent $4,350,873.00 General
Category: Continuous Glucose Monitoring
07/07/2020 Sonex Health, Inc. Sx-one Microknife (Device) Food and Beverage In-kind items and services $39.57 General
Category: Orthopedic
05/12/2020 Flexion Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $14.73 General
Category: Musculoskeletal
01/29/2020 Flexion Therapeutics, Inc. Zilretta (Drug) Food and Beverage In-kind items and services $15.80 General
Category: Musculoskeletal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 499 1,825 $449,674 $95,516
2022 11 553 2,074 $438,905 $118,581
2021 13 728 2,718 $540,770 $152,937
2020 12 762 1,938 $473,551 $123,759
Total Patients
2,542
Total Services
8,555
Medicare Billing
$490,794
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
27447 Replacement of knee joint, both sides of knee Facility 2023 28 28 $154,027 $20,799 13.5%
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg Office 2023 18 1,024 $24,576 $13,650 55.5%
J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose Office 2023 25 33 $41,184 $13,133 31.9%
27245 Treatment of broken neck of thigh bone with bone implant Facility 2023 12 12 $67,464 $11,718 17.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 167 247 $22,549 $10,080 44.7%
27130 Replacement of thigh bone and hip joint with prosthesis Facility 2023 14 14 $86,582 $9,857 11.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 76 76 $15,100 $6,795 45.0%
20610 Aspiration and/or injection of fluid from large joint Office 2023 65 89 $23,552 $4,939 21.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 37 39 $11,911 $3,829 32.1%
20550 Injection into tendon or ligament Office 2023 11 12 $2,096 $518.54 24.7%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 46 251 $632.50 $198.05 31.3%
J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose Office 2022 34 46 $61,152 $33,695 55.1%
27447 Replacement of knee joint, both sides of knee Facility 2022 21 21 $131,699 $18,207 13.8%
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg Office 2022 22 1,218 $30,768 $16,331 53.1%
27245 Treatment of broken neck of thigh bone with bone implant Facility 2022 14 14 $78,708 $13,873 17.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 162 237 $20,230 $10,414 51.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 109 109 $21,037 $9,113 43.3%
27130 Replacement of thigh bone and hip joint with prosthesis Facility 2022 13 13 $62,083 $6,487 10.4%
20610 Aspiration and/or injection of fluid from large joint Office 2022 78 106 $20,884 $5,397 25.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 34 34 $9,826 $3,683 37.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 11 11 $1,815 $1,161 64.0%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 55 265 $702.50 $220.89 31.4%
J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose Office 2021 25 39 $46,553 $36,094 77.5%
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg Office 2021 35 1,614 $39,288 $22,966 58.5%
27447 Repair of knee joint, lower or upper part of joint, inside and outside area Facility 2021 23 25 $125,968 $17,510 13.9%

About Dr. Marshall Ching, M.D

Dr. Marshall Ching, M.D is a Specialist healthcare provider based in Oroville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215036835.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Ching, M.D has received a total of $18.3M in payments from pharmaceutical and medical device companies, with $611,360 received in 2024. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Royalty or License" ($16.5M).

As a Medicare-enrolled provider, Ching has provided services to 2,542 Medicare beneficiaries, totaling 8,555 services with total Medicare billing of $490,794. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location Oroville, CA
  • Active Since 09/21/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1215036835

Products in Payments

  • InPen (Device) $15.3M
  • VenaSeal (Device) $1.4M
  • INPEN SMART INSULIN DELIVERY SYSTEM (Device) $610,829
  • ROSA (Device) $1,144
  • Zilretta (Drug) $213.24
  • Exparel (Drug) $54.05
  • Sx-one Microknife (Device) $39.57
  • VISCO-3 (Biological) $36.96
  • STRATAFIX (Device) $33.52
  • ZYNRELEF (Drug) $22.70
  • Neuromodulation Dspsbls and Accs (Device) $17.68
  • ULTRAGUIDECTR (Device) $17.00
  • OFIRMEV (Drug) $15.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Oroville